Cause-Specific Mortality in Patients with Chronic Kidney Disease and Atrial Fibrillation

Medha Airy1, Jesse D Schold2,3, Stacey E Jolly4

  • 1Selzman Institute for Kidney Health, Section of Nephrology, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.

Insights

Atrial fibrillation (AF) increases mortality risk in chronic kidney disease (CKD) patients. This study found AF linked to higher overall and cardiovascular death rates, but a lower risk of cancer mortality in CKD individuals.

Area of Science:

  • Nephrology
  • Cardiology
  • Epidemiology

Background:

  • Atrial fibrillation (AF) is a known risk factor for mortality in patients with chronic kidney disease (CKD).
  • Understanding the specific causes of death associated with AF in CKD is crucial for patient management.

Purpose of the Study:

  • To investigate the association between atrial fibrillation (AF) and cause-specific mortality in a large cohort of patients with chronic kidney disease (CKD).

Main Methods:

  • A cohort of 62,459 patients with CKD (estimated glomerular filtration rate 15-59 mL/min/1.73 m2) was analyzed, including 6,639 with AF.
  • Cox regression and competing risk models were employed to assess associations between AF and overall, cardiovascular, malignancy, and other causes of death.
  • Adjustments were made for demographics, comorbidities, laboratory data, medication use, and kidney function.

Main Results:

  • During a median follow-up of 4.1 years, AF was associated with a 23% higher risk of all-cause mortality and a 45% higher risk of cardiovascular mortality.
  • AF was also linked to a 13% lower risk of malignancy-related mortality.
  • These associations remained consistent across different stages of CKD.

Conclusions:

  • In non-dialysis-dependent CKD patients, AF is associated with increased all-cause and cardiovascular mortality.
  • Clinical practice and research should focus on mitigating the elevated cardiovascular risk in patients with both CKD and AF.
Abstract

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
742
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
673
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
481
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
401
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
12.0K
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.6K